Global Autoimmune Disease Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Autoimmune Disease Drugs market size was valued at US$ 146420 million in 2024 and is forecast to a readjusted size of USD 186630 million by 2031 with a CAGR of 3.5% during review period.

Autoimmune Disease Drugs refer to a class of drugs used to treat autoimmune diseases that are caused by the immune system mistakenly attacking the body's own tissues. These drugs are designed to regulate or suppress an overactive immune response to reduce symptoms, slow disease progression, and help patients maintain a normal quality of life. Common autoimmune disease drugs include anti-inflammatory drugs, immunosuppressants, biologics, etc., which act on the immune system through different mechanisms to control the condition and reduce damage to the body.

This report is a detailed and comprehensive analysis for global Autoimmune Disease Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Autoimmune Disease Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Autoimmune Disease Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Autoimmune Disease Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Autoimmune Disease Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Autoimmune Disease Drugs

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Autoimmune Disease Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qyuns Therapeutics, Bio-Thera Solutions, Hengrui Pharmaceuticals, Hisun Pharmaceutical, Sunshine Guojian Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Chongqing Genrix Biopharmaceutical, Keymed Biosciences, Junshi Biosciences, Akeso, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Autoimmune Disease Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Biopharma

Small Molecule Drug

Market segment by Application

Hospital

Clinic

Others

Major players covered

Qyuns Therapeutics

Bio-Thera Solutions

Hengrui Pharmaceuticals

Hisun Pharmaceutical

Sunshine Guojian Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Chongqing Genrix Biopharmaceutical

Keymed Biosciences

Junshi Biosciences

Akeso

AbbVie

AstraZeneca

Biogen

Bristol Myers Squibb

Eli Lilly

GlaxoSmithKline

Johnson & Johnson

Merck

Novartis AG

Pfizer

Roche Holding

Sanofi S.A.

Takeda Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Autoimmune Disease Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Autoimmune Disease Drugs, with price, sales quantity, revenue, and global market share of Autoimmune Disease Drugs from 2020 to 2025.

Chapter 3, the Autoimmune Disease Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Autoimmune Disease Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Autoimmune Disease Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Autoimmune Disease Drugs.

Chapter 14 and 15, to describe Autoimmune Disease Drugs sales channel, distributors, customers, research findings and conclusion.